Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced expanded regulatory and clinical trial services to international pharmaceutical and ...

The "Medical Device Regulatory Affairs Market Size, Share & Trends Analysis Report By Type, By Service Provider, By Service, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ...

Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "Global Handbook of Medical Devices Regulatory Affairs" directory has been added to ResearchAndMarkets.com's offering. This Handbook is the definitive ...

RALEIGH, N.C.--(BUSINESS WIRE)--Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry, announced today that it has acquired an ...

Polyrizon Ltd., a biotech company focused on innovative intranasal hydrogels, announced the appointment of Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs in preparation for its ...

Dublin, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The "European Handbook of Medical Devices Regulatory Affairs" directory has been added to ResearchAndMarkets.com's offering. This Handbook is the definitive ...

Polyrizon (PLRZ) announced the appointment of Dr. Michal Meir, Senior Consultant at MedTech, as Senior Director of Regulatory and Clinical Affairs. The appointment was made as part of the Company’s ...

In addition to improving payment speed, accuracy, and transparency, modern payment technology is creating new opportunities to further improve the trial experience. For example, AI is being used to ...

The Biotechnology Regulatory Affairs Graduate Certificate provides current training for professionals, who are directly or indirectly affected by biotechnology regulatory affairs. The demand for ...

NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury ...

Raanana, Israel, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal ...